Business Description
Excelsior Biopharma Inc
ISIN : TW0006496003
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.08 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | -16.08 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.2 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18 | |||||
3-Year Book Growth Rate | -5.1 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.95 | |||||
9-Day RSI | 55.19 | |||||
14-Day RSI | 54.09 | |||||
6-1 Month Momentum % | -1.93 | |||||
12-1 Month Momentum % | -11.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.14 | |||||
Quick Ratio | 3.06 | |||||
Cash Ratio | 2.22 | |||||
Days Inventory | 169.66 | |||||
Days Sales Outstanding | 70.54 | |||||
Days Payable | 43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -2.37 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 41.71 | |||||
Operating Margin % | -11.53 | |||||
Net Margin % | -13.03 | |||||
FCF Margin % | -41.82 | |||||
ROE % | -9.02 | |||||
ROA % | -5.92 | |||||
ROIC % | -12.66 | |||||
ROC (Joel Greenblatt) % | -14.61 | |||||
ROCE % | -6.39 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 11.15 | |||||
PS Ratio | 1.74 | |||||
PB Ratio | 1.26 | |||||
Price-to-Tangible-Book | 1.25 | |||||
EV-to-EBIT | -15.06 | |||||
EV-to-EBITDA | -45.13 | |||||
EV-to-Revenue | 1.67 | |||||
EV-to-FCF | -4.01 | |||||
Price-to-Projected-FCF | 1.25 | |||||
Price-to-Net-Current-Asset-Value | 4.38 | |||||
Earnings Yield (Greenblatt) % | -6.64 | |||||
FCF Yield % | -24.33 | |||||
Forward Rate of Return (Yacktman) % | -36.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Excelsior Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 773.691 | ||
EPS (TTM) (NT$) | -2.19 | ||
Beta | 0.08 | ||
Volatility % | 13.04 | ||
14-Day RSI | 54.09 | ||
14-Day ATR (NT$) | 0.199312 | ||
20-Day SMA (NT$) | 28.175 | ||
12-1 Month Momentum % | -11.13 | ||
52-Week Range (NT$) | 27 - 33.25 | ||
Shares Outstanding (Mil) | 46.99 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Excelsior Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Excelsior Biopharma Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Excelsior Biopharma Inc Frequently Asked Questions
What is Excelsior Biopharma Inc(ROCO:6496)'s stock price today?
When is next earnings date of Excelsior Biopharma Inc(ROCO:6496)?
Does Excelsior Biopharma Inc(ROCO:6496) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |